HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
25 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
ACTA1
actin alpha 1, skeletal muscle
Chromosome 1 Β· 1q42.13
NCBI Gene: 58Ensembl: ENSG00000143632.16HGNC: HGNC:129UniProt: P68133
460PubMed Papers
24Diseases
0Drugs
230Pathogenic Variants
FUNCTIONAL ROLE
Hub Gene
RESEARCH IMPACT
Highly StudiedTrendingVariant-Rich
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
stress fiberstriated muscle thin filamentactin filamentactin cytoskeletoncongenital myopathy 2a, typical, autosomal dominantprogressive scapulohumeroperoneal distal myopathycongenital myopathy 2c, severe infantile, autosomal dominantalpha-actinopathy
✦AI Summary

ACTA1 encodes skeletal muscle alpha-actin, the predominant actin isoform in sarcomeric thin filaments of adult skeletal muscle 1. It is essential for muscle contraction, functioning alongside myosin to generate myofibrillar force 12. ACTA1 mutations represent a major genetic cause of congenital myopathies, with 447 pathogenic/likely pathogenic variants now identified 3. The vast majority (74%) of variants cause nemaline myopathy, characterized by diagnostic nemaline rods in muscle fibers 34. ACTA1 mutations also produce five overlapping histopathological phenotypes including intranuclear rod myopathy, actin filament aggregates, congenital fiber-type disproportion, and core-like areas 1. Clinical phenotypes have expanded to 20 distinct presentations, with emerging cardiomyopathy phenotypes 35. Most mutations are dominant and de novo; only 10% are recessive genetic or functional nulls 1. Disease is frequently severe, with many patients experiencing rapid progression and early mortality 16. Genotype-position correlations help predict prognosis 4. Currently, only supportive treatment is available, though preclinical therapeutic strategies are under investigation 32.

Sources cited
1
ACTA1 encodes skeletal muscle alpha-actin in sarcomeric thin filaments, essential for muscle contraction; describes 177 disease-causing mutations and five overlapping congenital myopathy phenotypes
PMID: 19562689
2
Updates 607 total ACTA1 variants with 447 pathogenic/likely pathogenic variants; 74% cause nemaline myopathy with expanding phenotypes including cardiomyopathy and distal myopathy
PMID: 40225930
3
ACTA1-related nemaline myopathy shows variable clinical and histologic phenotypes; mutation position correlates with clinical presentation and prognosis
PMID: 28780987
4
ACTA1 mutations affect actin-myosin interaction and myofibril force production in congenital myopathies; supportive treatment is current mainstay with no cure available
PMID: 39223631
5
ACTA1 mutations are marked by de novo type with actin filament aggregates; cause early congenital onset with rapidly progressive course and early mortality
PMID: 19563543
6
ACTA1 R256H mutation causes dilated cardiomyopathy through dominant disruption of actin structure and cardiomyocyte contractility
PMID: 39503885
Disease Associationsβ“˜24
congenital myopathy 2a, typical, autosomal dominantOpen Targets
0.86Strong
progressive scapulohumeroperoneal distal myopathyOpen Targets
0.71Strong
congenital myopathy 2c, severe infantile, autosomal dominantOpen Targets
0.71Strong
alpha-actinopathyOpen Targets
0.69Moderate
congenital myopathy 2b, severe infantile, autosomal recessiveOpen Targets
0.68Moderate
severe congenital nemaline myopathyOpen Targets
0.67Moderate
nemaline myopathyOpen Targets
0.65Moderate
congenital fiber-type disproportion myopathyOpen Targets
0.60Moderate
congenital myopathyOpen Targets
0.49Moderate
neuromuscular diseaseOpen Targets
0.46Moderate
hypertrophic cardiomyopathyOpen Targets
0.45Moderate
myopathyOpen Targets
0.45Moderate
dilated cardiomyopathyOpen Targets
0.44Moderate
genetic disorderOpen Targets
0.44Moderate
fetal akinesia deformation sequenceOpen Targets
0.41Moderate
zebra body myopathyOpen Targets
0.38Weak
rigid spine syndromeOpen Targets
0.38Weak
typical nemaline myopathyOpen Targets
0.38Weak
childhood-onset nemaline myopathyOpen Targets
0.38Weak
intermediate nemaline myopathyOpen Targets
0.37Weak
Congenital myopathy 2A, typical, autosomal dominantUniProt
Congenital myopathy 2B, severe infantile, autosomal recessiveUniProt
Congenital myopathy 2C, severe infantile, autosomal dominantUniProt
Myopathy, scapulohumeroperonealUniProt
Pathogenic Variants230
NM_001100.4(ACTA1):c.442G>A (p.Gly148Ser)Likely pathogenic
Actin accumulation myopathy|not provided|Alpha-actinopathy
β˜…β˜…β˜…β˜†2025β†’ Residue 148
NM_001100.4(ACTA1):c.443G>T (p.Gly148Val)Likely pathogenic
Nemaline myopathy|Centronuclear myopathy|Alpha-actinopathy
β˜…β˜…β˜…β˜†2025β†’ Residue 148
NM_001100.4(ACTA1):c.442G>C (p.Gly148Arg)Likely pathogenic
not provided|Actin accumulation myopathy|Alpha-actinopathy
β˜…β˜…β˜…β˜†2025β†’ Residue 148
NM_001100.4(ACTA1):c.37G>A (p.Asp13Asn)Likely pathogenic
Actin accumulation myopathy|not specified|Alpha-actinopathy
β˜…β˜…β˜…β˜†2024β†’ Residue 13
NM_001100.4(ACTA1):c.1000C>T (p.Pro334Ser)Pathogenic
Congenital myopathy with fiber type disproportion|Actin accumulation myopathy|Congenital myopathy 2c, severe infantile, autosomal dominant|Alpha-actinopathy|Progressive scapulohumeroperoneal distal myopathy
β˜…β˜…β˜…β˜†2024β†’ Residue 334
NM_001100.4(ACTA1):c.304G>A (p.Glu102Lys)Likely pathogenic
not provided|Actin accumulation myopathy|Alpha-actinopathy|Myopathy
β˜…β˜…β˜…β˜†2024β†’ Residue 102
NM_001100.4(ACTA1):c.175G>A (p.Glu59Lys)Likely pathogenic
not provided|Nemaline myopathy|Alpha-actinopathy
β˜…β˜…β˜…β˜†2024β†’ Residue 59
NM_001100.4(ACTA1):c.1001C>T (p.Pro334Leu)Likely pathogenic
Actin accumulation myopathy|not provided|Alpha-actinopathy
β˜…β˜…β˜…β˜†2024β†’ Residue 334
NM_001100.4(ACTA1):c.172G>A (p.Asp58Asn)Likely pathogenic
not provided|Actin accumulation myopathy|Alpha-actinopathy
β˜…β˜…β˜…β˜†2024β†’ Residue 58
NM_001100.4(ACTA1):c.493G>A (p.Val165Met)Pathogenic
Actin accumulation myopathy|not provided|Alpha-actinopathy
β˜…β˜…β˜…β˜†2024β†’ Residue 165
NM_001100.4(ACTA1):c.1127G>T (p.Cys376Phe)Likely pathogenic
Actin accumulation myopathy|Alpha-actinopathy
β˜…β˜…β˜…β˜†2024β†’ Residue 376
NM_001100.4(ACTA1):c.124C>T (p.His42Tyr)Pathogenic
Actin accumulation myopathy|Congenital myopathy 2c, severe infantile, autosomal dominant|Alpha-actinopathy
β˜…β˜…β˜…β˜†2024β†’ Residue 42
NM_001100.4(ACTA1):c.109G>T (p.Val37Leu)Pathogenic
Actin accumulation myopathy|Alpha-actinopathy|not provided
β˜…β˜…β˜…β˜†2024β†’ Residue 37
NM_001100.4(ACTA1):c.1106C>T (p.Pro369Leu)Pathogenic
not provided|Actin accumulation myopathy|Alpha-actinopathy
β˜…β˜…β˜…β˜†2024β†’ Residue 369
NM_001100.4(ACTA1):c.283G>A (p.Glu95Lys)Pathogenic
Actin accumulation myopathy|Congenital myopathy|Alpha-actinopathy
β˜…β˜…β˜…β˜†2024β†’ Residue 95
NM_001100.4(ACTA1):c.1043T>A (p.Leu348Gln)Likely pathogenic
not provided|Actin accumulation myopathy|Alpha-actinopathy
β˜…β˜…β˜…β˜†2024β†’ Residue 348
NM_001100.4(ACTA1):c.1127G>C (p.Cys376Ser)Pathogenic
Alpha-actinopathy
β˜…β˜…β˜…β˜†2024β†’ Residue 376
NM_001100.4(ACTA1):c.1074G>T (p.Trp358Cys)Likely pathogenic
Actin accumulation myopathy|Alpha-actinopathy
β˜…β˜…β˜…β˜†2024β†’ Residue 358
NM_001100.4(ACTA1):c.414C>G (p.Ile138Met)Likely pathogenic
Actin accumulation myopathy|Alpha-actinopathy
β˜…β˜…β˜…β˜†2024β†’ Residue 138
NM_001100.4(ACTA1):c.1054T>C (p.Ser352Pro)Likely pathogenic
Actin accumulation myopathy|Alpha-actinopathy
β˜…β˜…β˜…β˜†2024β†’ Residue 352
View on ClinVar β†—
Related Genes
CTNNA1Protein interaction100%VASPProtein interaction100%ARPC1BProtein interaction100%ACTR3Protein interaction100%WIPF1Protein interaction100%MYH7Protein interaction100%
Tissue Expression6 tissues
Heart
100%
Lung
0%
Liver
0%
Ovary
0%
Brain
0%
Bone Marrow
0%
Gene Interaction Network
Click a node to explore
ACTA1CTNNA1VASPARPC1BACTR3WIPF1MYH7
PROTEIN STRUCTURE
Preparing viewer…
PDB7RNS Β· 1.14 Γ… Β· X-ray
View on RCSB β†—
Constraintβ“˜
LOEUFβ“˜
0.93LoF Tolerant
pLIβ“˜
0.00Tolerant
Observed/Expected LoF0.67 [0.48–0.93]
RankingsWhere ACTA1 stands among ~20K protein-coding genes
  • #590of 20,598
    Most Researched460 Β· top 5%
  • #279of 5,498
    Most Pathogenic Variants230 Β· top 10%
  • #8,595of 17,882
    Most Constrained (LOEUF)0.93
Genes detectedACTA1
Sources retrieved25 papers
Response timeβ€”
πŸ“„ Sources
25β–Ό
1
Mutations and polymorphisms of the skeletal muscle alpha-actin gene (ACTA1).
PMID: 19562689
Hum Mutat Β· 2009
1.00
2
A 20-year Clinical and Genetic Neuromuscular Cohort Analysis in Lebanon: An International Effort.
PMID: 34602496
J Neuromuscul Dis Β· 2022
0.90
3
An Update on Reported Variants in the Skeletal Muscle
PMID: 40225930
Hum Mutat Β· 2024
0.80
4
Nemaline myopathies: a current view.
PMID: 31228046
J Muscle Res Cell Motil Β· 2019
0.72
5
Congenital myopathies: pathophysiological mechanisms and promising therapies.
PMID: 39223631
J Transl Med Β· 2024
0.70